Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

vit d.PDF

Van Pesch, Vincent [UCL]

Sindic, Christian [UCL]

Document type	Article de périodique (Journal article) – Article de recherche
Access type	Accès libre
Publication date	2012
Language	Anglais
Journal information	"Acta neurologica Belgica" - Vol. 112, no.4, p. 325 (2012)
Peer reviewed	yes
issn	0300-9009
Publication status	Publié
Affiliations	UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire UCL - (SLuc) Service de neurologie
Links	http://hdl.handle.net/2078.1/124392[Handle] https://doi.org/10.1007/s13760-012-0162-6[DOI] http://www.ncbi.nlm.nih.gov/pubmed/23160809[Pubmed]

Runia T. F., Hop W. C. J., de Rijke Y. B., Buljevac D., Hintzen R. Q., Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis, 10.1212/wnl.0b013e31825fdec7
Mowry Ellen M., Waubant Emmanuelle, McCulloch Charles E., Okuda Darin T., Evangelista Alan A., Lincoln Robin R., Gourraud Pierre-Antoine, Brenneman Don, Owen Mary C., Qualley Pamela, Bucci Monica, Hauser Stephen L., Pelletier Daniel, Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis, 10.1002/ana.23591
Stein M. S., Liu Y., Gray O. M., Baker J. E., Kolbe S. C., Ditchfield M. R., Egan G. F., Mitchell P. J., Harrison L. C., Butzkueven H., Kilpatrick T. J., A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis, 10.1212/wnl.0b013e3182343274
Dörr Jan, Ohlraun Stephanie, Skarabis Horst, Paul Friedemann, Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial, 10.1186/1745-6215-13-15
Smolders Joost, Hupperts Raymond, Barkhof Frederik, Grimaldi Luigi M.E., Holmoy Trygve, Killestein Joep, Rieckmann Peter, Schluep Myriam, Vieth Reinhold, Hostalek Ulrike, Ghazi-Visser Lizette, Beelke Manolo, Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial, 10.1016/j.jns.2011.04.013

Bibliographic reference	Van Pesch, Vincent ; Sindic, Christian. Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?. In: Acta neurologica Belgica, Vol. 112, no.4, p. 325 (2012)
Permanent URL	http://hdl.handle.net/2078.1/124392